[
  {
    "ts": "2026-01-17T03:05:00+00:00",
    "headline": "This Company Is Doubling Down on AI. Is the Stock a Buy?",
    "summary": "The pharmaceutical leader continues to grab headlines.",
    "url": "https://www.fool.com/investing/2026/01/16/this-company-is-doubling-down-on-ai-is-the-stock-a/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "eb0662f2-dc10-3fd0-b82c-19dca767e853",
      "content": {
        "id": "eb0662f2-dc10-3fd0-b82c-19dca767e853",
        "contentType": "STORY",
        "title": "This Company Is Doubling Down on AI. Is the Stock a Buy?",
        "description": "",
        "summary": "The pharmaceutical leader continues to grab headlines.",
        "pubDate": "2026-01-17T03:05:00Z",
        "displayTime": "2026-01-17T03:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/2b08d34f1176c16a20179ed7b2c8031e",
          "originalWidth": 1400,
          "originalHeight": 738,
          "caption": "Person raising both fists in the air.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DgR7FAXuHyMbsAr1QHCu_g--~B/aD03Mzg7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/2b08d34f1176c16a20179ed7b2c8031e.cf.webp",
              "width": 1400,
              "height": 738,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9uFADLWHD_pkdBwfJt6.pw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/2b08d34f1176c16a20179ed7b2c8031e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/16/this-company-is-doubling-down-on-ai-is-the-stock-a/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/company-doubling-down-ai-stock-030500560.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVDA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-17T11:45:30+00:00",
    "headline": "BMO Reaffirms Eli Lilly and Company (LLY) as an Obesity Market Leader",
    "summary": "Eli Lilly and Company (NYSE:LLY) is among the stocks with the best earnings growth for the next 5 years. On January 14, BMO Capital reaffirmed an ‘Outperform’ rating on Eli Lilly and Company (NYSE:LLY) with a price target of $1,200. Matching the consensus 1-year median target price, the stock has an upside potential of 16.36%. […]",
    "url": "https://finance.yahoo.com/news/bmo-reaffirms-eli-lilly-company-114530772.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "2fb67a61-cfee-3227-b37f-bc3ea72bfe3d",
      "content": {
        "id": "2fb67a61-cfee-3227-b37f-bc3ea72bfe3d",
        "contentType": "STORY",
        "title": "BMO Reaffirms Eli Lilly and Company (LLY) as an Obesity Market Leader",
        "description": "",
        "summary": "Eli Lilly and Company (NYSE:LLY) is among the stocks with the best earnings growth for the next 5 years. On January 14, BMO Capital reaffirmed an ‘Outperform’ rating on Eli Lilly and Company (NYSE:LLY) with a price target of $1,200. Matching the consensus 1-year median target price, the stock has an upside potential of 16.36%. […]",
        "pubDate": "2026-01-17T11:45:30Z",
        "displayTime": "2026-01-17T11:45:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4297bceadd7b3662bc208031885247f5",
          "originalWidth": 700,
          "originalHeight": 500,
          "caption": "Eli Lilly and Company (LLY) Announces Updated Meaningful Data on Breast Cancer Treatment",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Wyy4UWrSKL87q_fyeH45LA--~B/aD01MDA7dz03MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4297bceadd7b3662bc208031885247f5.cf.webp",
              "width": 700,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AnFYVFBsFAzROcOJguXtPQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4297bceadd7b3662bc208031885247f5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bmo-reaffirms-eli-lilly-company-114530772.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bmo-reaffirms-eli-lilly-company-114530772.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVDA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-17T19:00:00+00:00",
    "headline": "Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026?",
    "summary": "The pharmaceutical leader has plenty of cash and is using it effectively.",
    "url": "https://www.fool.com/investing/2026/01/17/could-acquiring-ventyx-biosciences-send-eli-lilly/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "dbd4bf06-51e5-33d4-8a72-3d73f29f0bea",
      "content": {
        "id": "dbd4bf06-51e5-33d4-8a72-3d73f29f0bea",
        "contentType": "STORY",
        "title": "Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026?",
        "description": "",
        "summary": "The pharmaceutical leader has plenty of cash and is using it effectively.",
        "pubDate": "2026-01-17T19:00:00Z",
        "displayTime": "2026-01-17T19:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/a0783ba87ad37e0e835a45340663007f",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Physician shaking businessperson's hand. ",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eX9oEGfrN3XytJBLP6Fj6A--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/a0783ba87ad37e0e835a45340663007f.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tnyusQOEWPcDmxQ7uzwFmg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/a0783ba87ad37e0e835a45340663007f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/17/could-acquiring-ventyx-biosciences-send-eli-lilly/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/could-acquiring-ventyx-biosciences-send-190000841.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "VTYX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]